TORONTO STOCK EXCHANGE · ONCY
-1.20% · -$0.0096 · Vol 571.3K
Market closed · last close 4:00 PM ET · price as of 19:00:00 ET
Oncolytics Biotech Inc

Oncolytics Biotech Inc

Biotechnology
$0.7910
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
ONCY
Oncolytics Biotech Inc
Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

51/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ONCY moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ONCY catalysts
About Oncolytics Biotech Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2001
Employees
29
Country
CA

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.8045
Day high
$0.8200
Day low
$0.7929
Previous close
$0.8006
52W high
$1.42
-44.30% from high
52W low
$0.7516
6% of range
Market cap
$95.6M
EPS
$-0.3200
Beta
1.70
Shares out
119.4M
Volume
571.3K
0.44× rel vol
Avg volume
1.3M
VWAP
$0.8061
Price history computed in-house
1W
+5.00%
1M
-14.02%
3M
-11.11%
1Y
-7.85%
YTD
-9.50%
SMA 50 $0.8703 · below
SMA 200 $0.9611 · below
52W position 6%

ONCY overview

Veridion Score
51
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ONCY.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ONCY Form 4 filings
Public disclosures

Congress activity in ONCY

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ONCY in the cached public ledger.

Federal contracts

ONCY contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ONCY in this window.
Lobbying spend

ONCY lobbying filings, year to date.

Registered lobbying filings matched to Oncolytics Biotech Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ONCY in this window.
Loading news for ONCY
Analyst ratings
Sovereign unlock shows live analyst consensus for ONCY.
Options
Sovereign unlock shows live options positioning for ONCY.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.